LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2

EMBO Journal

Volumn 18, Issue 9, 1999, Pages 2511-2521

  Kieser, Arnd ^a   Kaiser, Christian ^a   Hammerschmidt, Wolfgang ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

c Jun N terminal kinase 1; Latent membrane protein 1; Nuclear factor B; Signal transduction; TNF receptor 1

Indexed keywords

CELL CYCLE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; RECEPTOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION;

ANTIGENS, CD; BINDING SITES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MUTATION; NF-KAPPA B; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 0033522511     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.9.2511     Document Type: Article

References (55)

1. Arch, R.H., Gedrich, R.W. and Thompson, C.B. (1998) Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev., 12, 2821-2830.
2. Baichwal, V.R. and Sugden, B. (1988) Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene, 2, 461-467.
3. Berberich, I., Shu, G., Siebelt, F., Woodgett, J.R., Kyriakis, J.M. and Clark, E.A. (1996) Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J., 15, 92-101.
4. Bost, F., McKay, R., Dean, N. and Mercola, D. (1997) The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem., 272, 33422-33429.
5. Brodeur, S.R., Cheng, G., Baltimore, D. and Thorley-Lawson, D.A. (1997) Localization of the major NF-κB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J. Biol. Chem., 272, 19777-19784.
6. Chinnaiyan, A.M., O'Rourke, K., Tewari, M. and Dixit, V.M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-512.
7. Chinnaiyan, A.M. et al. (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science, 274, 990-992.
8. Coso, O.A., Chiariello, M., Yu, J.C., Teramoto, H., Crespo, P., Xu, N., Miki, T. and Gutkind, J.S. (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell, 81, 1137-1146.
9. Devergne, O., Hatzivassiliou, E., Izumi, K.M., Kaye, K.M., Kleijnen, M.F., Kieff, E. and Mosialos, G. (1996) Association of TRAF1, TRAF2 and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol., 16, 7098-7108.
10. Eliopoulos, A.G. and Young, L.S. (1998) Activation of the c-Jun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene, 16, 1731-1742.
11. Eliopoulos, A.G., Stack, M., Dawson, C.W., Kaye, K.M., Hodgkin, L., Sihota, S., Rowe, M. and Young, L.S. (1997) Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene, 14, 2899-2916.
12. Farrell, P.J. (1995) Epstein-Barr virus immortalizing genes. Trends Microbiol., 3, 105-109.
13. Farrell, P.J. (1998) Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. Trends Microbiol., 6, 175-177.
14. Floettmann, J.E. and Rowe, M. (1997) Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-κB activation. Oncogene, 15, 1851-1858.
15. Floettmann, J.E., Eliopoulos, A.G., Jones, M., Young, L.S. and Rowe, M. (1998) Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions. Oncogene, 17, 2383-2392.
16. Gires, O., Zimber-Strobl, U., Gonnella, R., Ueffing, M., Marschall, G., Zeidler, R., Pich, D. and Hammerschmidt, W. (1997) Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J., 16, 6131-6140.
17. Henderson, S., Rowe, M., Gregory, C., Croom, C.D., Wang, F. and Longnecker, R. (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65, 1107-1115.
18. Hill, C.S., Wynne, J. and Treisman, R. (1995) The Rho family GTPases RhoA, Rac1 and CDC42Hs regulate transcriptional activation by SRF. Cell, 81, 1159-1170.
19. Hsu, H., Xiong, J. and Goeddel, D.V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell, 81, 495-504.
20. Hsu, H., Huang, J., Shu, H.B., Baichwal, V. and Goeddel, D.V. (1996a) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity, 4, 387-396.
21. Hsu, H., Shu, H.B., Pan, M.G. and Goeddel, D.V. (1996b) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84, 299-308.
22. Huen, D.S., Henderson, S.A., Croom-Carter, D. and Rowe, M. (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene, 10, 549-560.
23. Izumi, K.M. and Kieff, E.D. (1997) The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl Acad Sci. USA, 94, 12592-12597.
24. Just, I., Selzer, J., Wilm, M., von Eichel-Streiber, C., Mann, M. and Aktories, K. (1995) Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature, 375, 500-503.
25. Kaye, K.M., Izumi, K.M. and Kieff, E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci. USA, 90, 9150-9154.
26. Kaye, K.M., Devergne, O., Harada, J.N., Izumi, K.M., Yalamanchili, R., Kieff, E. and Mosialos, G. (1996) Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl Acad. Sci. USA, 93, 11085-11090.
27. Kieff, E. (1996) Epstein-Barr virus and its replication. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Monath, T.P., Melnick, J.L., Roizman, B. and Straus, S.E. (eds), Virology. Lippincott-Raven Publishers, Philadelphia, PA, pp. 2343-2396.
28. Kieser, A., Kilger, E., Gires, O., Ueffing, M., Kolch, W. and Hammerschmidt, W. (1997) Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J., 16, 6478-6485.
29. Kilger, E., Kieser, A., Baumann, M. and Hammerschmidt, W. (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J., 17, 1700-1709.
30. Klein, G. (1994) Epstein-Barr virus strategy in normal and neoplastic B cells. Cell, 77, 791-793.
31. Kulwichit, W., Edwards, R.H., Davenport, E.M., Baskar, J.F., Godfrey, V. and Raab-Traub, N. (1998) Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl Acad. Sci. USA, 95, 11963-11968.
32. Kyriakis, J.M. and Avruch, J. (1996) Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem., 271, 24313-24316.
33. Laherty, C.D., Hu, H.M., Opipari, A.W., Wang, F. and Dixit, V.M. (1992) The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB. J. Biol. Chem., 267, 24157-24160.
34. Lee, S.Y., Reichlin, A., Santana, A., Sokol, K.A., Nussenzweig, M.C. and Choi, Y. (1997) TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity, 7, 703-713.
35. Liebowitz, D., Wang, D. and Kieff, E. (1986) Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J. Virol., 58, 233-237.
36. Liu, Z.G., Hsu, H., Goeddel, D.V. and Karin, M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell, 87, 565-576.
37. Malinin, N.L., Boldin, M.P., Kovalenko, A.V. and Wallach, D. (1997) MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature, 385, 540-544.
38. Martin, J.M., Veis, D., Korsmeyer, S.J. and Sugden, B. (1993) Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J. Virol., 67, 5269-5278.
39. Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Derijard, B., Davis, R.J., Johnson, G.L. and Karin, M. (1994) Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science, 266, 1719-1723.
40. Minden, A., Lin, A., Claret, F.X., Abo, A. and Karin, M. (1995) Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 81, 1147-1157.
41. Mitchell, T. and Sugden, B. (1995) Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol., 69, 2968-2976.
42. Moorthy, R.K. and Thorley-Lawson, D.A. (1993) All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J. Virol., 67, 1638-1646.
43. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C. and Kieff, E. (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell, 80, 389-399.
44. Natoli, G., Costanzo, A., Ianni, A., Templeton, D.J., Woodgett, J.R., Balsano, C. and Levrero, M. (1997) Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science, 275, 200-203.
45. Niedobitek, G., Young, L.S. and Herbst, H. (1997) Epstein-Barr virus infection and the pathogenesis of malignant lymphomas. In Wotherspoon, A.C. (ed.), Lymphoma. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 143-162.
46. Park, A. and Baichwal, V.R. (1996) Systematic mutational analysis of the death domain of the tumor necrosis factor receptor 1-associated protein TRADD. J. Biol. Chem., 271, 9858-9862.
47. Rothe, M., Sarma, V., Dixit, V.M. and Goeddel, D.V. (1995) TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science, 269, 1424-1427.
48. Rowe, M., Evans, H.S., Young, L.S., Hennessy, K., Kieff, E. and Rickinson, A.B. (1987) Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J. Gen. Virol., 68, 1575-1586.
49. Sandberg, M., Hammerschmidt, W. and Sugden, B. (1997) Characterization of LMP-1's association with TRAF1, TRAF2 and TRAF3. J. Virol., 71, 4649-4656.
50. Seshagiri, S. and Miller, L.K. (1997) Baculovirus inhibitors of apoptosis (IAPs) block activation of Sf-caspase-1. Proc. Natl Acad. Sci. USA, 94, 13606-13611.
51. Stanger, B.Z., Leder, P., Lee, T.H., Kim, E. and Seed, B. (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81, 513-523.
52. Sylla, B.S., Hung, S.C, Davidson, D.M., Hatzivassiliou, E., Malinin, N.L., Wallach, D., Gilmore, T.D., Kieff, E. and Mosialos, G. (1998) Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κB through a pathway that includes the NF-κB-inducing kinase and the 1KB kinases IKKα and IKKβ. Proc. Natl Acad. Sci. USA, 95, 10106-10111.
53. Tartaglia, L.A., Ayres, T.M., Wong, G.H. and Goeddel, D.V. (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell, 74, 845-853.
54. Wang, D., Liebowitz, D. and Kieff, E. (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell, 43, 831-840.
55. Yuan, J. (1997) Transducing signals of life and death. Curr. Opin. Cell Biol., 9, 247-251.